HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ro 25-6981

blocks NMDA receptors containg NR2B subunit; structure in first source
Also Known As:
Ro-25-6981; Ro25,6981; alpha-(4-hydroxyphenyl)-beta-methyl--4-(phenylmethyl)-1-piperidine propanol
Networked: 30 relevant articles (5 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Di Paolo, Thérèse: 2 articles (10/2013 - 06/2009)
2. Grégoire, Laurent: 2 articles (10/2013 - 06/2009)
3. Morissette, Marc: 2 articles (10/2013 - 06/2009)
4. Konitsiotis, Spiridon: 2 articles (05/2012 - 04/2006)
5. Tsironis, Christos: 2 articles (05/2012 - 04/2006)
6. Herrera, Jairo: 2 articles (05/2012 - 01/2011)
7. Bausch, Suzanne B: 2 articles (07/2010 - 12/2004)
8. Kozlová, Lucie: 1 article (09/2021)
9. Kubová, Hana: 1 article (09/2021)
10. Mareš, Pavel: 1 article (09/2021)

Related Diseases

1. Dyskinesias (Dyskinesia)
2. Seizures (Absence Seizure)
3. Hyperalgesia
4. Pain (Aches)
5. Shock

Related Drugs and Biologics

1. ifenprodil
2. 2-Amino-5-phosphonovalerate (2 Amino 5 phosphonovalerate)
3. Amantadine (Aman)
4. Acids
5. 2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)
6. Remifentanil (Ultiva)
7. N-Methyl-D-Aspartate Receptors (NMDA Receptors)
8. N-Methylaspartate (NMDA)
9. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
10. Levodopa (L Dopa)

Related Therapies and Procedures

1. Analgesia
2. Spinal Injections
3. Aftercare (After-Treatment)